1. Home
  2. MHO vs MRUS Comparison

MHO vs MRUS Comparison

Compare MHO & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MHO
  • MRUS
  • Stock Information
  • Founded
  • MHO 1976
  • MRUS 2003
  • Country
  • MHO United States
  • MRUS Netherlands
  • Employees
  • MHO N/A
  • MRUS N/A
  • Industry
  • MHO Homebuilding
  • MRUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MHO Consumer Discretionary
  • MRUS Health Care
  • Exchange
  • MHO Nasdaq
  • MRUS Nasdaq
  • Market Cap
  • MHO 3.2B
  • MRUS 2.8B
  • IPO Year
  • MHO 1986
  • MRUS 2016
  • Fundamental
  • Price
  • MHO $116.79
  • MRUS $47.37
  • Analyst Decision
  • MHO Buy
  • MRUS Strong Buy
  • Analyst Count
  • MHO 3
  • MRUS 13
  • Target Price
  • MHO $176.50
  • MRUS $85.67
  • AVG Volume (30 Days)
  • MHO 350.9K
  • MRUS 526.2K
  • Earning Date
  • MHO 01-29-2025
  • MRUS 03-07-2025
  • Dividend Yield
  • MHO N/A
  • MRUS N/A
  • EPS Growth
  • MHO 21.59
  • MRUS N/A
  • EPS
  • MHO 19.71
  • MRUS N/A
  • Revenue
  • MHO $4,504,670,000.00
  • MRUS $35,932,000.00
  • Revenue This Year
  • MHO $4.65
  • MRUS N/A
  • Revenue Next Year
  • MHO $7.64
  • MRUS $42.15
  • P/E Ratio
  • MHO $5.93
  • MRUS N/A
  • Revenue Growth
  • MHO 11.68
  • MRUS N/A
  • 52 Week Low
  • MHO $109.92
  • MRUS $37.77
  • 52 Week High
  • MHO $176.18
  • MRUS $61.61
  • Technical
  • Relative Strength Index (RSI)
  • MHO 36.48
  • MRUS 71.36
  • Support Level
  • MHO $112.83
  • MRUS $39.67
  • Resistance Level
  • MHO $121.96
  • MRUS $41.15
  • Average True Range (ATR)
  • MHO 3.71
  • MRUS 1.71
  • MACD
  • MHO 0.26
  • MRUS 0.86
  • Stochastic Oscillator
  • MHO 36.23
  • MRUS 91.57

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks: